Liver Diseases  >>  Isentress (raltegravir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
NCT00782301: Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Withdrawn
4
0
US, Canada, Europe
maraviroc, Selzentry, etravirine
ViiV Healthcare, Pfizer
Hepatitis B, Human Immunodeficiency Virus, Hepatitis C, Chronic
02/10
02/10

Download Options